Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD

Trial Profile

Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Aug 2016

At a glance

  • Drugs Glycopyrrolate/indacaterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms CREATES
  • Most Recent Events

    • 08 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 04 Aug 2016 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
    • 04 Aug 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top